Landscape review and analysis of Canada’s pharmaceutical drug data and advice to support the development of a national drug data strategy (1000234416)
Process Number PW-21-00975033
Dates:
2021-11-17 00:00:00
Amendment date:None
Date closing:2021/11/19 14:00 Eastern Standard Time (EST)
Details:
National Capital Region
Health Canada
Health Canada
Canada
Selective
PW-21-00975033
1000234416
Description:
The Canadian Drug Agency Transition Office requires one (1) Senior Level Business Consultant to provide expert analysis with respect to developing a data strategy for the pharmaceutical management system. The analysis will include three distinct phases of work: Phase 1 – Review of the Drug Data Landscape, Phase 2 – Analysis of Barriers, Strengths and Opportunities for improving access to Drug Data and Phase 3 – Advice on getting started and the Canadian Drug Agency’s role. The Business Consultant will be required over a period of approximately 14 weeks.
Contact information:
Phillips, Wesley
Contact email:wesley.phillips@canada.ca
Contact phone:613-941-2067
200 Eglantine Ottawa ON K1A 0K9 CA
Contact Fax:Solicitation Documents:
| File | Amendment Number | Language | Date added |
|---|
Attachments:
| File | Amendment Number | Language | Date added |
|---|---|---|---|
| pr1000234416_npp_english.docx | Not available | Bilingual | 2021-11-17 |
| pr1000234416_npp_french.docx | Not available | Bilingual | 2021-11-17 |